Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe E. who wrote (3062)	12/2/1997 11:54:00 AM
From: Steve Fancy	Read Replies (2) of 6136

Excuse my crudeness, but this really pisses me off. In looking at daily closing figures, the stock broke 40 the day after discussions were supposedly initiated with Roche. I wonder if she sold out. No wonder I felt her comments on Thymitaq after the conference call were vague. We could see some further downside without some positive news and reinforcement the companies a good buy coming across the wires. The folks who bought on the two day rebound to 40 really got taken for a ride - at least in the short term. Any regular posters here who would like further information can email me at smfmlf@centuryinter.net. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next